Center Laboratories, Inc. (4123.TWO)
- Previous Close
43.85 - Open
43.85 - Bid 43.35 x --
- Ask 43.45 x --
- Day's Range
43.30 - 43.85 - 52 Week Range
40.80 - 61.64 - Volume
220,369 - Avg. Volume
1,361,277 - Market Cap (intraday)
29.775B - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
-- - EPS (TTM)
-1.50 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield 0.99 (2.26%)
- Ex-Dividend Date Sep 8, 2023
- 1y Target Est
--
Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally. It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses. The company also supplies glass fibre pressure vessels. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.
www.centerlab.com.tw--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 4123.TWO
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4123.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4123.TWO
Valuation Measures
Market Cap
30.08B
Enterprise Value
31.16B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
20.89
Price/Book (mrq)
1.52
Enterprise Value/Revenue
22.35
Enterprise Value/EBITDA
-40.68
Financial Highlights
Profitability and Income Statement
Profit Margin
-71.41%
Return on Assets (ttm)
0.19%
Return on Equity (ttm)
-5.31%
Revenue (ttm)
1.39B
Net Income Avi to Common (ttm)
-995.42M
Diluted EPS (ttm)
-1.50
Balance Sheet and Cash Flow
Total Cash (mrq)
3.42B
Total Debt/Equity (mrq)
27.81%
Levered Free Cash Flow (ttm)
-2.37B
Research Analysis: 4123.TWO
Company Insights: 4123.TWO
4123.TWO does not have Company Insights